annual Report 2009 - STRATEC Biomedical AG

More documents

Recommendations

Info

Stock option program V (SOP V) Stock option program V was adopted by the Annual General Meeting on May 20, 2009. The following option rights were allocated on the basis of this resolution (each option right entitles the bearer to acquire on STRATEC share): (17) / 1 st tranche of SOP V On the basis of a contract dated June 26, 2009, 65,000 option rights were granted to members of the Board of Management of STRATEC AG. (18) / 2 nd tranche of SOP V On the basis of a contract dated October 1, 2009, 5,800 option rights were granted to employees of STRATEC AG. (19) / 3 rd tranche of SOP V On the basis of a contract dated November 1, 2009, 1,500 option rights were granted to employees of STRATEC AG. Taking due account of the expected level of personnel turnover, the total value (at the respective date of issue) of the stock options so far granted to members of the Board of Management and employees of STRATEC AG, as well as to the management and employees of associates, amounts to u 1,007 thousand (previous year: u 787 thousand). The total value of the option rights has been spread as personnel expenses over the agreed qualifying periods and has resulted in an endowment of the same amount in the capital reserve. This led to personnel expenses of u 220 thousand in the 2009 financial year (previous year: u 164 thousand). Given the consistent, low level of personnel turnover, it has not been necessary in subsequent periods to adjust the personnel expenses calculated upon the respective rights being granted. 82 stratec Annual Report 2009
Report of the board of Management Report of the supervisory board THE share Corporate Governance Group Management report Consolidated financial statements Service The following options schedule provides an overview of the development in option rights: Number of option rights Weighted exercise price in v Outstanding on 12.31.2004 168,000 7.93 During the 2005 financial year granted 14,250 29.15 exercised 30,250 3.18 lapsed 0 n.a. Outstanding on 12.31.2005 152,000 10.86 During the 2006 financial year granted 30,300 16.97 exercised 82,320 7.88 lapsed 0 n.a. Outstanding on 12.31.2006 99,980 15.15 During the 2007 financial year granted 75,600 22.62 exercised 51,941 12.75 lapsed 5,500 n.a. Outstanding on 12.31.2007 118,139 20.34 During the 2008 financial year granted 92,300 12.16 exercised 3,322 13.51 lapsed 1,200 n.a. Outstanding on 12.31.2008 205,917 16.81 Exercisable on 12.31.2008 7,442 14.97 During the 2009 financial year granted 117,800 13.48 exercised 14,487 16.67 lapsed 100 n.a. Outstanding on 12.31.2009 309,130 15.55 Exercisable on 12.31.2009 61,230 20.28 The option rights exercisable as of December 31, 2009 entitle their bearers to acquire a total of up to 76,445 shares at a total exercise price of u 1,241 thousand. The weighted average share price of the stock options exercised during the reporting period amounted to u 22.96 (previous year: u 15.14). stratec Annual Report 2009 83
Page 1 and 2:
2009 Annual Report
Page 3 and 4:
Key figures at a glance and Locatio
Page 5 and 6:
committed to quality proven partner
Page 7 and 8:
Report of the board of Management R
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
6:50 7:30 7.00 a.m. Getting ready t
Page 15 and 16:
10:38 11:40 8.38 a.m. Talking to th
Page 17 and 18:
3:08 4:12 1.55 p.m. Analyzing the b
Page 19 and 20:
6:55 7:25 4.20 p.m. Getting the res
Page 21 and 22:
10:08 10:20 Just one example of wha
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36: Report of the board of Management R
Page 85: Report of the board of Management R
show all

annual Report 2009 - STRATEC Biomedical AG

Create successful ePaper yourself

Delete template?

Save as template?